Comments
Loading...

TScan Therapeutics

TCRXNASDAQ
Logo brought to you by Benzinga Data
$2.58
0.083.20%
At close: -
$2.58
0.000.00%
After Hours: 4:00 PM EDT

TScan Therapeutics (NASDAQ:TCRX) Stock, Earnings Estimates, EPS, And Revenue

TScan Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Mar 5
EPS Estimate
$-0.280
Quarterly Revenue Estimate
$1.51M
Annual Revenue
(as of Sep 30)
$9.36M

Analyze the earnings history of TScan Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

TScan Therapeutics (TCRX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32024-11-12$-0.25$-0.2913.8 %
Q22024-08-12$-0.28$-0.280.00 %
Q12024-05-13$-0.32$-0.25-28.0 %
Q42024-03-06$-0.21$-0.2927.6 %

TScan Therapeutics (TCRX) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32024-11-12$1.05M$1.06M-1.04 %
Q22024-08-12$536.00K$2.42M-77.8 %
Q12024-05-13$566.00K$3.97M-85.7 %
Q42024-03-06$7.21M$3.34M115.9 %

FAQ

Q

When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?

A

TScan Therapeutics (TCRX) is scheduled to report earnings on March 5, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for TScan Therapeutics (NASDAQ:TCRX)?

A

The Actual EPS was $-0.25, which beat the estimate of $-0.29.

Q

What were TScan Therapeutics’s (NASDAQ:TCRX) revenues?

A

The Actual Revenue was $1M, which missed the estimate of $1.1M.

Browse earnings estimates, EPS, and revenue on all stocks.